LifeMD, Inc. (LFMD) 10-Year Financial Performance & Capital Metrics

LFMD • • Industrial / General

HealthcarePharmaceuticalsDigital Health & TelemedicineDirect-to-Patient Telehealth

AboutLifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.Show more

Revenue $212M +39.3%
EBITDA -$7M +15.7%
Net Income -$19M +8.3%
EPS (Diluted) -0.53 +24.3%
Gross Margin 88.67% +1.2%
EBITDA Margin -3.13% +39.4%
Operating Margin -7.6% +20.0%
Net Margin -8.89% +34.2%
ROE -2483.15% -571.1%
ROIC -
Debt/Equity -
Interest Coverage -7.40 -32.6%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 76.3%
✓Healthy dividend yield of 2.0%
✓Efficient asset utilization: 2.9x turnover

✗Weaknesses

✗Weak momentum: RS Rating 8 (bottom 8%)
✗Shares diluted 21.5% in last year
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y76.74%

5Y76.32%

3Y31.76%

TTM30.79%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM79.11%

EPS CAGR

10Y-

5Y-

3Y-

TTM70.09%

ROCE

10Y Avg-461.2%

5Y Avg-266.51%

3Y Avg-219.09%

Latest-89.93%

Peer Comparison

Direct-to-Patient Telehealth

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
LFMDLifeMD, Inc.	181.47M	3.77	-7.11	39.27%	-1.82%	-136.65%	3.29%

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	1.22M	5.24M	5.05M	8.32M	12.47M	37.29M	92.88M	119.03M	152.55M	212.45M
Revenue Growth %	0.71%	3.3%	-0.04%	0.65%	0.5%	1.99%	1.49%	0.28%	0.28%	0.39%
Cost of Goods Sold+	247.77K	1.95M	1.48M	1.97M	2.53M	8.86M	18M	18.67M	18.9M	24.07M
COGS % of Revenue	0.2%	0.37%	0.29%	0.24%	0.2%	0.24%	0.19%	0.16%	0.12%	0.11%
Gross Profit+	971.09K	3.29M	3.57M	6.36M	9.94M	28.43M	74.88M	100.37M	133.65M	188.39M
Gross Margin %	0.8%	0.63%	0.71%	0.76%	0.8%	0.76%	0.81%	0.84%	0.88%	0.89%
Gross Profit Growth %	0.79%	2.39%	0.08%	0.78%	0.56%	1.86%	1.63%	0.34%	0.33%	0.41%
Operating Expenses+	1.23M	4.47M	4.64M	8.41M	12.83M	86.25M	129.18M	143.81M	148.14M	204.53M
OpEx % of Revenue	1.01%	0.85%	0.92%	1.01%	1.03%	2.31%	1.39%	1.21%	0.97%	0.96%
Selling, General & Admin	1.21M	4.47M	4.64M	8.41M	11.31M	84.01M	122.08M	125.33M	128.15M	175.68M
SG&A % of Revenue	0.99%	0.85%	0.92%	1.01%	0.91%	2.25%	1.31%	1.05%	0.84%	0.83%
Research & Development	23.93K	0	0	120.54K	222.88K	446.75K	948.16K	2.97M	6.06M	9.51M
R&D % of Revenue	0.02%	-	-	0.01%	0.02%	0.01%	0.01%	0.02%	0.04%	0.04%
Other Operating Expenses	0	0	0	-516.98K	1.3M	1.79M	6.16M	15.51M	13.93M	19.34M
Operating Income+	-262.22K	-1.17M	-1.07M	-2.06M	-2.89M	-57.82M	-54.3M	-43.45M	-14.49M	-16.14M
Operating Margin %	-0.22%	-0.22%	-0.21%	-0.25%	-0.23%	-1.55%	-0.58%	-0.37%	-0.09%	-0.08%
Operating Income Growth %	0.51%	-3.48%	0.09%	-0.93%	-0.41%	-19.01%	0.06%	0.2%	0.67%	-0.11%
EBITDA+	-218.47K	-1.13M	160.82K	-1.86M	-2.55M	-57.48M	-53.95M	-42.36M	-7.89M	-6.65M
EBITDA Margin %	-0.18%	-0.22%	0.03%	-0.22%	-0.2%	-1.54%	-0.58%	-0.36%	-0.05%	-0.03%
EBITDA Growth %	0.54%	-4.18%	1.14%	-12.57%	-0.37%	-21.51%	0.06%	0.21%	0.81%	0.16%
D&A (Non-Cash Add-back)	43.75K	43.75K	1.23M	195.78K	335.61K	335.61K	355.87K	1.09M	6.6M	9.49M
EBIT	-134.96K	-1.17M	-1.28M	-2.06M	-2.89M	-57.82M	-54.3M	-39.69M	-14.49M	-16.14M
Net Interest Income+	-37.48K	-48.61K	-100.52K	-354.39K	-761.15K	-1.67M	-3.02M	-1.28M	-2.6M	-2.18M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	37.48K	48.61K	100.52K	354.39K	761.15K	1.67M	3.02M	1.28M	2.6M	2.18M
Other Income/Expense	89.78K	-48.61K	-150.91K	-354.39K	-761.15K	-2.58M	-7.02M	-1.21M	-2.92M	-2.18M
Pretax Income+	-172.43K	-1.22M	-1.22M	-1.48M	-3.65M	-60.4M	-61.32M	-44.66M	-17.41M	-18.33M
Pretax Margin %	-0.14%	-0.23%	-0.24%	-0.18%	-0.29%	-1.62%	-0.66%	-0.38%	-0.11%	-0.09%
Income Tax+	-13.2K	0	-12.49K	-124.7K	-122.5K	122.5K	7.7K	360.7K	428K	402K
Effective Tax Rate %	0.36%	0.91%	0.99%	0.84%	0.86%	0.97%	0.99%	1.02%	1.18%	1.03%
Net Income+	-61.99K	-1.11M	-1.21M	-1.24M	-3.14M	-58.65M	-60.9M	-45.54M	-20.6M	-18.88M
Net Margin %	-0.05%	-0.21%	-0.24%	-0.15%	-0.25%	-1.57%	-0.66%	-0.38%	-0.14%	-0.09%
Net Income Growth %	0.87%	-16.87%	-0.09%	-0.03%	-1.53%	-17.69%	-0.04%	0.25%	0.55%	0.08%
Net Income (Continuing)	-159.23K	-1.22M	-1.38M	-2.29M	-3.53M	-60.52M	-61.32M	-45.02M	-17.84M	-18.73M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	80.91K	-6.55K	-259.08K	-77.96K	-141.06K	-2.18M	-1.03M	-475.55K	2.06M	1.44M
EPS (Diluted)+	-0.01	-0.16	-0.14	-0.14	-0.36	-4.24	-2.27	-1.45	-0.70	-0.53
EPS Growth %	0.87%	-	0.13%	0%	-1.57%	-10.78%	0.46%	0.36%	0.52%	0.24%
EPS (Basic)	-0.01	-0.16	-0.14	-0.14	-0.36	-4.24	-2.27	-1.45	-0.70	-0.53
Diluted Shares Outstanding	6.4M	7.05M	8.8M	9.05M	9.9M	14.28M	27.01M	30.98M	33.91M	41.2M
Basic Shares Outstanding	6.16M	7.05M	8.8M	8.84M	9.9M	14.28M	27.01M	30.98M	33.91M	41.2M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	448.47K	789.82K	1.26M	1.61M	2.75M	12.41M	44.92M	11.31M	42.6M	48.73M
Cash & Short-Term Investments	232.98K	182.56K	141.38K	180.09K	1.11M	9.18M	41.33M	3.96M	33.15M	35M
Cash Only	232.98K	182.56K	141.38K	180.09K	1.11M	9.18M	41.33M	3.96M	33.15M	35M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	154.44K	446.99K	128.19K	99.05K	97.45K	997.76K	980.05K	2.83M	5.28M	8.22M
Days Sales Outstanding	46.25	31.14	9.26	4.34	2.85	9.77	3.85	8.69	12.63	14.12
Inventory	61.05K	160.27K	707.16K	1.02M	950.06K	1.26M	1.62M	3.7M	2.76M	2.8M
Days Inventory Outstanding	89.94	30.06	173.97	189.56	137.32	52.08	32.79	72.41	53.3	42.42
Other Current Assets	0	0	296.48K	270.01K	442.97K	154.88K	793.19K	687.02K	934.51K	2.67M
Total Non-Current Assets+	0	0	0	1.01M	699.08K	990.26K	5M	14.35M	15.88M	23.73M
Property, Plant & Equipment	0	0	0	0	23.63K	274.44K	1.99M	1.68M	1.07M	7.88M
Fixed Asset Turnover	-	-	-	-	527.77x	135.89x	46.76x	70.75x	142.41x	26.96x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	1.01M	675.45K	715.82K	3.02M	12.67M	14.81M	15.85M
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	0	0	0	0	0	0	0	0	0	0
Total Assets+	448.47K	789.82K	1.26M	2.62M	3.45M	13.4M	49.92M	25.67M	58.48M	72.46M
Asset Turnover	2.72x	6.63x	4.00x	3.18x	3.62x	2.78x	1.86x	4.64x	2.61x	2.93x
Asset Growth %	1.56%	0.76%	0.6%	1.07%	0.32%	2.89%	2.72%	-0.49%	1.28%	0.24%
Total Current Liabilities+	267.48K	1.15M	640.97K	1.19M	3.98M	13.93M	22.83M	31.37M	34.78M	60.26M
Accounts Payable	167.48K	752.93K	473.49K	869K	3M	10.41M	9.06M	10.11M	11.08M	16.01M
Days Payables Outstanding	246.72	141.22	116.48	161.08	433.34	428.72	183.75	197.61	214.07	242.78
Short-Term Debt	100K	206.37K	167.48K	247.42K	814.73K	779.13K	63.4K	2.8M	327.6K	8.44M
Deferred Revenue (Current)	-167.48K	0	-473.49K	75.98K	0	916.88K	1000K	1000K	1000K	1000K
Other Current Liabilities	-167.48K	-560.68K	-422.35K	-869K	109.55K	237.04K	1.66M	576.03K	10.93M	5.11M
Current Ratio	1.68x	0.69x	1.97x	1.35x	0.69x	0.89x	1.97x	0.36x	1.22x	0.81x
Quick Ratio	1.45x	0.55x	0.87x	0.49x	0.45x	0.80x	1.90x	0.24x	1.15x	0.76x
Cash Conversion Cycle	-110.54	-80.01	66.74	32.82	-293.17	-366.88	-147.11	-116.51	-148.14	-186.24
Total Non-Current Liabilities+	0	0	0	604K	599.98K	292.32K	1.28M	1.6M	18.13M	16.25M
Long-Term Debt	0	0	0	0	0	0	0	0	17.93M	9.89M
Capital Lease Obligations	0	0	0	0	29.98K	192.32K	1.18M	574.14K	73.85K	6.27M
Deferred Tax Liabilities	0	0	0	4K	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	600K	570K	100K	100K	1.02M	131.25K	100K
Total Liabilities	267.48K	1.15M	640.97K	1.8M	4.58M	14.22M	24.1M	32.97M	52.91M	76.51M
Total Debt+	100K	206.37K	167.48K	247.42K	844.71K	1.06M	1.85M	4.13M	18.93M	25.1M
Net Debt	-132.98K	23.8K	26.1K	67.32K	-261.91K	-8.11M	-39.48M	168.52K	-14.21M	-9.9M
Debt / Equity	0.55x	-	0.27x	0.30x	-	-	0.07x	-	3.40x	-
Debt / EBITDA	-	-	1.04x	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	0.16x	-	-	-	-	-	-	-
Interest Coverage	-7.00x	-24.16x	-10.62x	-5.80x	-3.80x	-34.67x	-17.98x	-34.05x	-5.58x	-7.40x
Total Equity+	180.99K	-361.73K	622.84K	819.74K	-1.13M	-821.76K	25.82M	-7.31M	5.57M	-4.05M
Equity Growth %	2.3%	-3%	2.72%	0.32%	-2.38%	0.27%	32.42%	-1.28%	1.76%	-1.73%
Book Value per Share	0.03	-0.05	0.07	0.09	-0.11	-0.06	0.96	-0.24	0.16	-0.10
Total Shareholders' Equity	100.08K	-355.17K	881.92K	897.7K	-988.18K	1.35M	26.85M	-6.83M	3.51M	-5.49M
Common Stock	320.1K	355.7K	444.93K	457.82K	106.81K	234.34K	307.05K	315.53K	383.59K	422.94K
Retained Earnings	-8.59M	-9.69M	-10.9M	-12.14M	-16.59M	-80.15M	-141.92M	-190.56M	-214.27M	-236.25M
Treasury Stock	0	-87.05K	-163.7K	-163.7K	-163.7K	-163.7K	-163.7K	-163.7K	-163.7K	-163.7K
Accumulated OCI	-679.29K	0	0	0	0	0	0	0	0	0
Minority Interest	80.91K	-6.55K	-259.08K	-77.96K	-141.06K	-2.18M	-1.03M	-475.55K	2.06M	1.44M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-295.12K	-407.91K	-817.22K	-905.52K	251.41K	-12.13M	-33.09M	-22.94M	8.82M	17.51M
Operating CF Margin %	-0.24%	-0.08%	-0.16%	-0.11%	0.02%	-0.33%	-0.36%	-0.19%	0.06%	0.08%
Operating CF Growth %	-9.83%	-0.38%	-1%	-0.11%	1.28%	-49.25%	-1.73%	0.31%	1.38%	0.99%
Net Income	-159.23K	-1.22M	-1.21M	-1.36M	-3.53M	-60.52M	-61.32M	-45.02M	-20.6M	-18.73M
Depreciation & Amortization	43.75K	33.72K	91.56K	195.78K	335.61K	397.76K	868.76K	3.77M	6.6M	9.49M
Stock-Based Compensation	142.3K	587.99K	162.74K	273.57K	733.22K	18.66M	12.07M	13.73M	12.49M	12.23M
Deferred Taxes	-13.2K	37.42K	-90.28K	4K	66K	914.86K	0	354K	0	0
Other Non-Cash Items	-127.26K	33.72K	918.01K	237.2K	578.61K	19.63M	6.17M	5.78M	5.42M	1.87M
Working Capital Changes	-181.48K	122.54K	-693.28K	-255.97K	2.07M	8.8M	9.13M	-1.55M	4.91M	12.65M
Change in Receivables	-139.47K	-361.44K	95.09K	29.14K	1.6K	-550.97K	17.7K	-2.19M	-2.44M	-2.94M
Change in Inventory	-20.04K	-99.22K	-546.89K	-341.36K	72.56K	-314.2K	-409.82K	-2.18M	764.33K	675.67K
Change in Payables	-21.97K	585.45K	-227.23K	6.34K	1.89M	8.93M	-893.96K	1.25M	978.06K	4.92M
Cash from Investing+	127.26K	219.89K	63.38K	141.44K	-100K	-798.14K	-3.4M	-13.91M	-8.73M	-11.54M
Capital Expenditures	0	0	0	-100K	0	-398.14K	-247.37K	-366.63K	-203.81K	-1.49M
CapEx % of Revenue	-	-	-	0.01%	-	0.01%	0%	0%	0%	0.01%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	127.26K	0	0	290K	-100K	0	-3.15M	-12.53M	-8.53M	-10.05M
Cash from Financing+	325.35K	357.49K	776.03K	802.79K	775.12K	21M	68.64M	-528.2K	29.1M	-4.12M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-10.8K	0	0	0	0	-1.29M	-871.48K	-3.11M	-3.11M	-3.11M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	188.95K	249.89K	63.38K	160.35K	-373.15K	2.07M	707.36K	-159.2K	-667.63K	-684.83K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-295.12K	-407.91K	-817.22K	-1.01M	251.41K	-12.53M	-36.49M	-35.83M	86.95K	5.98M
FCF Margin %	-0.24%	-0.08%	-0.16%	-0.12%	0.02%	-0.34%	-0.39%	-0.3%	0%	0.03%
FCF Growth %	-9.83%	-0.38%	-1%	-0.23%	1.25%	-50.84%	-1.91%	0.02%	1%	67.74%
FCF per Share	-0.05	-0.06	-0.09	-0.11	0.03	-0.88	-1.35	-1.16	0.00	0.15
FCF Conversion (FCF/Net Income)	4.76x	0.37x	0.68x	0.73x	-0.08x	0.21x	0.54x	0.50x	-0.43x	-0.93x
Interest Paid	0	0	0	0	0	0	435.05K	189K	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-298.81%	-	-923.7%	-172.03%	-	-	-487.23%	-491.92%	-370.02%	-2483.15%
Return on Invested Capital (ROIC)	-409.66%	-	-514.86%	-200.79%	-	-	-	-	-	-
Gross Margin	79.67%	62.85%	70.65%	76.35%	79.75%	76.24%	80.62%	84.32%	87.61%	88.67%
Net Margin	-5.09%	-21.14%	-23.86%	-14.91%	-25.16%	-157.26%	-65.57%	-38.25%	-13.5%	-8.89%
Debt / Equity	0.55x	-	0.27x	0.30x	-	-	0.07x	-	3.40x	-
Interest Coverage	-7.00x	-24.16x	-10.62x	-5.80x	-3.80x	-34.67x	-17.98x	-34.05x	-5.58x	-7.40x
FCF Conversion	4.76x	0.37x	0.68x	0.73x	-0.08x	0.21x	0.54x	0.50x	-0.43x	-0.93x
Revenue Growth	70.67%	329.79%	-3.51%	64.68%	49.79%	199.1%	149.04%	28.16%	28.15%	39.27%

Revenue by Segment

	2019	2020	2021
Work simpli	-	-	445.84K
Work simpli Growth	-	-	-
Product Revenues, Net	9.92M	30.56M	-
Product Revenues, Net Growth	-	208.04%	-
Software Revenues, Net	2.54M	6.73M	-
Software Revenues, Net Growth	-	165.16%	-
Service Revenues, Net	9.94K	5K	-
Service Revenues, Net Growth	-	-49.71%	-

Frequently Asked Questions

Growth & Financials

LifeMD, Inc. (LFMD) reported $252.3M in revenue for fiscal year 2024. This represents a 33825% increase from $0.7M in 2011.

LifeMD, Inc. (LFMD) grew revenue by 39.3% over the past year. This is strong growth.

LifeMD, Inc. (LFMD) reported a net loss of $4.6M for fiscal year 2024.

Dividend & Returns

Yes, LifeMD, Inc. (LFMD) pays a dividend with a yield of 2.00%. This makes it attractive for income-focused investors.

LifeMD, Inc. (LFMD) has a return on equity (ROE) of -2483.1%. Negative ROE indicates the company is unprofitable.

LifeMD, Inc. (LFMD) generated $17.0M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...

LifeMD, Inc. (LFMD) 10-Year Financial Performance & Capital Metrics

LFMD • • Industrial / General

HealthcarePharmaceuticalsDigital Health & TelemedicineDirect-to-Patient Telehealth

Revenue $212M +39.3%
EBITDA -$7M +15.7%
Net Income -$19M +8.3%
EPS (Diluted) -0.53 +24.3%
Gross Margin 88.67% +1.2%
EBITDA Margin -3.13% +39.4%
Operating Margin -7.6% +20.0%
Net Margin -8.89% +34.2%
ROE -2483.15% -571.1%
ROIC -
Debt/Equity -
Interest Coverage -7.40 -32.6%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong 5Y sales CAGR of 76.3%
✓Healthy dividend yield of 2.0%
✓Efficient asset utilization: 2.9x turnover

✗Weaknesses

✗Weak momentum: RS Rating 8 (bottom 8%)
✗Shares diluted 21.5% in last year
✗Trading more than 30% below 52-week high

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y76.74%

5Y76.32%

3Y31.76%

TTM30.79%

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM79.11%

EPS CAGR

10Y-

5Y-

3Y-

TTM70.09%

ROCE

10Y Avg-461.2%

5Y Avg-266.51%

3Y Avg-219.09%

Latest-89.93%

Peer Comparison

Direct-to-Patient Telehealth

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
LFMDLifeMD, Inc.	181.47M	3.77	-7.11	39.27%	-1.82%	-136.65%	3.29%

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	1.22M	5.24M	5.05M	8.32M	12.47M	37.29M	92.88M	119.03M	152.55M	212.45M
Revenue Growth %	0.71%	3.3%	-0.04%	0.65%	0.5%	1.99%	1.49%	0.28%	0.28%	0.39%
Cost of Goods Sold+	247.77K	1.95M	1.48M	1.97M	2.53M	8.86M	18M	18.67M	18.9M	24.07M
COGS % of Revenue	0.2%	0.37%	0.29%	0.24%	0.2%	0.24%	0.19%	0.16%	0.12%	0.11%
Gross Profit+	971.09K	3.29M	3.57M	6.36M	9.94M	28.43M	74.88M	100.37M	133.65M	188.39M
Gross Margin %	0.8%	0.63%	0.71%	0.76%	0.8%	0.76%	0.81%	0.84%	0.88%	0.89%
Gross Profit Growth %	0.79%	2.39%	0.08%	0.78%	0.56%	1.86%	1.63%	0.34%	0.33%	0.41%
Operating Expenses+	1.23M	4.47M	4.64M	8.41M	12.83M	86.25M	129.18M	143.81M	148.14M	204.53M
OpEx % of Revenue	1.01%	0.85%	0.92%	1.01%	1.03%	2.31%	1.39%	1.21%	0.97%	0.96%
Selling, General & Admin	1.21M	4.47M	4.64M	8.41M	11.31M	84.01M	122.08M	125.33M	128.15M	175.68M
SG&A % of Revenue	0.99%	0.85%	0.92%	1.01%	0.91%	2.25%	1.31%	1.05%	0.84%	0.83%
Research & Development	23.93K	0	0	120.54K	222.88K	446.75K	948.16K	2.97M	6.06M	9.51M
R&D % of Revenue	0.02%	-	-	0.01%	0.02%	0.01%	0.01%	0.02%	0.04%	0.04%
Other Operating Expenses	0	0	0	-516.98K	1.3M	1.79M	6.16M	15.51M	13.93M	19.34M
Operating Income+	-262.22K	-1.17M	-1.07M	-2.06M	-2.89M	-57.82M	-54.3M	-43.45M	-14.49M	-16.14M
Operating Margin %	-0.22%	-0.22%	-0.21%	-0.25%	-0.23%	-1.55%	-0.58%	-0.37%	-0.09%	-0.08%
Operating Income Growth %	0.51%	-3.48%	0.09%	-0.93%	-0.41%	-19.01%	0.06%	0.2%	0.67%	-0.11%
EBITDA+	-218.47K	-1.13M	160.82K	-1.86M	-2.55M	-57.48M	-53.95M	-42.36M	-7.89M	-6.65M
EBITDA Margin %	-0.18%	-0.22%	0.03%	-0.22%	-0.2%	-1.54%	-0.58%	-0.36%	-0.05%	-0.03%
EBITDA Growth %	0.54%	-4.18%	1.14%	-12.57%	-0.37%	-21.51%	0.06%	0.21%	0.81%	0.16%
D&A (Non-Cash Add-back)	43.75K	43.75K	1.23M	195.78K	335.61K	335.61K	355.87K	1.09M	6.6M	9.49M
EBIT	-134.96K	-1.17M	-1.28M	-2.06M	-2.89M	-57.82M	-54.3M	-39.69M	-14.49M	-16.14M
Net Interest Income+	-37.48K	-48.61K	-100.52K	-354.39K	-761.15K	-1.67M	-3.02M	-1.28M	-2.6M	-2.18M
Interest Income	0	0	0	0	0	0	0	0	0	0
Interest Expense	37.48K	48.61K	100.52K	354.39K	761.15K	1.67M	3.02M	1.28M	2.6M	2.18M
Other Income/Expense	89.78K	-48.61K	-150.91K	-354.39K	-761.15K	-2.58M	-7.02M	-1.21M	-2.92M	-2.18M
Pretax Income+	-172.43K	-1.22M	-1.22M	-1.48M	-3.65M	-60.4M	-61.32M	-44.66M	-17.41M	-18.33M
Pretax Margin %	-0.14%	-0.23%	-0.24%	-0.18%	-0.29%	-1.62%	-0.66%	-0.38%	-0.11%	-0.09%
Income Tax+	-13.2K	0	-12.49K	-124.7K	-122.5K	122.5K	7.7K	360.7K	428K	402K
Effective Tax Rate %	0.36%	0.91%	0.99%	0.84%	0.86%	0.97%	0.99%	1.02%	1.18%	1.03%
Net Income+	-61.99K	-1.11M	-1.21M	-1.24M	-3.14M	-58.65M	-60.9M	-45.54M	-20.6M	-18.88M
Net Margin %	-0.05%	-0.21%	-0.24%	-0.15%	-0.25%	-1.57%	-0.66%	-0.38%	-0.14%	-0.09%
Net Income Growth %	0.87%	-16.87%	-0.09%	-0.03%	-1.53%	-17.69%	-0.04%	0.25%	0.55%	0.08%
Net Income (Continuing)	-159.23K	-1.22M	-1.38M	-2.29M	-3.53M	-60.52M	-61.32M	-45.02M	-17.84M	-18.73M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	80.91K	-6.55K	-259.08K	-77.96K	-141.06K	-2.18M	-1.03M	-475.55K	2.06M	1.44M
EPS (Diluted)+	-0.01	-0.16	-0.14	-0.14	-0.36	-4.24	-2.27	-1.45	-0.70	-0.53
EPS Growth %	0.87%	-	0.13%	0%	-1.57%	-10.78%	0.46%	0.36%	0.52%	0.24%
EPS (Basic)	-0.01	-0.16	-0.14	-0.14	-0.36	-4.24	-2.27	-1.45	-0.70	-0.53
Diluted Shares Outstanding	6.4M	7.05M	8.8M	9.05M	9.9M	14.28M	27.01M	30.98M	33.91M	41.2M
Basic Shares Outstanding	6.16M	7.05M	8.8M	8.84M	9.9M	14.28M	27.01M	30.98M	33.91M	41.2M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	448.47K	789.82K	1.26M	1.61M	2.75M	12.41M	44.92M	11.31M	42.6M	48.73M
Cash & Short-Term Investments	232.98K	182.56K	141.38K	180.09K	1.11M	9.18M	41.33M	3.96M	33.15M	35M
Cash Only	232.98K	182.56K	141.38K	180.09K	1.11M	9.18M	41.33M	3.96M	33.15M	35M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	154.44K	446.99K	128.19K	99.05K	97.45K	997.76K	980.05K	2.83M	5.28M	8.22M
Days Sales Outstanding	46.25	31.14	9.26	4.34	2.85	9.77	3.85	8.69	12.63	14.12
Inventory	61.05K	160.27K	707.16K	1.02M	950.06K	1.26M	1.62M	3.7M	2.76M	2.8M
Days Inventory Outstanding	89.94	30.06	173.97	189.56	137.32	52.08	32.79	72.41	53.3	42.42
Other Current Assets	0	0	296.48K	270.01K	442.97K	154.88K	793.19K	687.02K	934.51K	2.67M
Total Non-Current Assets+	0	0	0	1.01M	699.08K	990.26K	5M	14.35M	15.88M	23.73M
Property, Plant & Equipment	0	0	0	0	23.63K	274.44K	1.99M	1.68M	1.07M	7.88M
Fixed Asset Turnover	-	-	-	-	527.77x	135.89x	46.76x	70.75x	142.41x	26.96x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	1.01M	675.45K	715.82K	3.02M	12.67M	14.81M	15.85M
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	0	0	0	0	0	0	0	0	0	0
Total Assets+	448.47K	789.82K	1.26M	2.62M	3.45M	13.4M	49.92M	25.67M	58.48M	72.46M
Asset Turnover	2.72x	6.63x	4.00x	3.18x	3.62x	2.78x	1.86x	4.64x	2.61x	2.93x
Asset Growth %	1.56%	0.76%	0.6%	1.07%	0.32%	2.89%	2.72%	-0.49%	1.28%	0.24%
Total Current Liabilities+	267.48K	1.15M	640.97K	1.19M	3.98M	13.93M	22.83M	31.37M	34.78M	60.26M
Accounts Payable	167.48K	752.93K	473.49K	869K	3M	10.41M	9.06M	10.11M	11.08M	16.01M
Days Payables Outstanding	246.72	141.22	116.48	161.08	433.34	428.72	183.75	197.61	214.07	242.78
Short-Term Debt	100K	206.37K	167.48K	247.42K	814.73K	779.13K	63.4K	2.8M	327.6K	8.44M
Deferred Revenue (Current)	-167.48K	0	-473.49K	75.98K	0	916.88K	1000K	1000K	1000K	1000K
Other Current Liabilities	-167.48K	-560.68K	-422.35K	-869K	109.55K	237.04K	1.66M	576.03K	10.93M	5.11M
Current Ratio	1.68x	0.69x	1.97x	1.35x	0.69x	0.89x	1.97x	0.36x	1.22x	0.81x
Quick Ratio	1.45x	0.55x	0.87x	0.49x	0.45x	0.80x	1.90x	0.24x	1.15x	0.76x
Cash Conversion Cycle	-110.54	-80.01	66.74	32.82	-293.17	-366.88	-147.11	-116.51	-148.14	-186.24
Total Non-Current Liabilities+	0	0	0	604K	599.98K	292.32K	1.28M	1.6M	18.13M	16.25M
Long-Term Debt	0	0	0	0	0	0	0	0	17.93M	9.89M
Capital Lease Obligations	0	0	0	0	29.98K	192.32K	1.18M	574.14K	73.85K	6.27M
Deferred Tax Liabilities	0	0	0	4K	0	0	0	0	0	0
Other Non-Current Liabilities	0	0	0	600K	570K	100K	100K	1.02M	131.25K	100K
Total Liabilities	267.48K	1.15M	640.97K	1.8M	4.58M	14.22M	24.1M	32.97M	52.91M	76.51M
Total Debt+	100K	206.37K	167.48K	247.42K	844.71K	1.06M	1.85M	4.13M	18.93M	25.1M
Net Debt	-132.98K	23.8K	26.1K	67.32K	-261.91K	-8.11M	-39.48M	168.52K	-14.21M	-9.9M
Debt / Equity	0.55x	-	0.27x	0.30x	-	-	0.07x	-	3.40x	-
Debt / EBITDA	-	-	1.04x	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	0.16x	-	-	-	-	-	-	-
Interest Coverage	-7.00x	-24.16x	-10.62x	-5.80x	-3.80x	-34.67x	-17.98x	-34.05x	-5.58x	-7.40x
Total Equity+	180.99K	-361.73K	622.84K	819.74K	-1.13M	-821.76K	25.82M	-7.31M	5.57M	-4.05M
Equity Growth %	2.3%	-3%	2.72%	0.32%	-2.38%	0.27%	32.42%	-1.28%	1.76%	-1.73%
Book Value per Share	0.03	-0.05	0.07	0.09	-0.11	-0.06	0.96	-0.24	0.16	-0.10
Total Shareholders' Equity	100.08K	-355.17K	881.92K	897.7K	-988.18K	1.35M	26.85M	-6.83M	3.51M	-5.49M
Common Stock	320.1K	355.7K	444.93K	457.82K	106.81K	234.34K	307.05K	315.53K	383.59K	422.94K
Retained Earnings	-8.59M	-9.69M	-10.9M	-12.14M	-16.59M	-80.15M	-141.92M	-190.56M	-214.27M	-236.25M
Treasury Stock	0	-87.05K	-163.7K	-163.7K	-163.7K	-163.7K	-163.7K	-163.7K	-163.7K	-163.7K
Accumulated OCI	-679.29K	0	0	0	0	0	0	0	0	0
Minority Interest	80.91K	-6.55K	-259.08K	-77.96K	-141.06K	-2.18M	-1.03M	-475.55K	2.06M	1.44M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-295.12K	-407.91K	-817.22K	-905.52K	251.41K	-12.13M	-33.09M	-22.94M	8.82M	17.51M
Operating CF Margin %	-0.24%	-0.08%	-0.16%	-0.11%	0.02%	-0.33%	-0.36%	-0.19%	0.06%	0.08%
Operating CF Growth %	-9.83%	-0.38%	-1%	-0.11%	1.28%	-49.25%	-1.73%	0.31%	1.38%	0.99%
Net Income	-159.23K	-1.22M	-1.21M	-1.36M	-3.53M	-60.52M	-61.32M	-45.02M	-20.6M	-18.73M
Depreciation & Amortization	43.75K	33.72K	91.56K	195.78K	335.61K	397.76K	868.76K	3.77M	6.6M	9.49M
Stock-Based Compensation	142.3K	587.99K	162.74K	273.57K	733.22K	18.66M	12.07M	13.73M	12.49M	12.23M
Deferred Taxes	-13.2K	37.42K	-90.28K	4K	66K	914.86K	0	354K	0	0
Other Non-Cash Items	-127.26K	33.72K	918.01K	237.2K	578.61K	19.63M	6.17M	5.78M	5.42M	1.87M
Working Capital Changes	-181.48K	122.54K	-693.28K	-255.97K	2.07M	8.8M	9.13M	-1.55M	4.91M	12.65M
Change in Receivables	-139.47K	-361.44K	95.09K	29.14K	1.6K	-550.97K	17.7K	-2.19M	-2.44M	-2.94M
Change in Inventory	-20.04K	-99.22K	-546.89K	-341.36K	72.56K	-314.2K	-409.82K	-2.18M	764.33K	675.67K
Change in Payables	-21.97K	585.45K	-227.23K	6.34K	1.89M	8.93M	-893.96K	1.25M	978.06K	4.92M
Cash from Investing+	127.26K	219.89K	63.38K	141.44K	-100K	-798.14K	-3.4M	-13.91M	-8.73M	-11.54M
Capital Expenditures	0	0	0	-100K	0	-398.14K	-247.37K	-366.63K	-203.81K	-1.49M
CapEx % of Revenue	-	-	-	0.01%	-	0.01%	0%	0%	0%	0.01%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	127.26K	0	0	290K	-100K	0	-3.15M	-12.53M	-8.53M	-10.05M
Cash from Financing+	325.35K	357.49K	776.03K	802.79K	775.12K	21M	68.64M	-528.2K	29.1M	-4.12M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-10.8K	0	0	0	0	-1.29M	-871.48K	-3.11M	-3.11M	-3.11M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	188.95K	249.89K	63.38K	160.35K	-373.15K	2.07M	707.36K	-159.2K	-667.63K	-684.83K
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-295.12K	-407.91K	-817.22K	-1.01M	251.41K	-12.53M	-36.49M	-35.83M	86.95K	5.98M
FCF Margin %	-0.24%	-0.08%	-0.16%	-0.12%	0.02%	-0.34%	-0.39%	-0.3%	0%	0.03%
FCF Growth %	-9.83%	-0.38%	-1%	-0.23%	1.25%	-50.84%	-1.91%	0.02%	1%	67.74%
FCF per Share	-0.05	-0.06	-0.09	-0.11	0.03	-0.88	-1.35	-1.16	0.00	0.15
FCF Conversion (FCF/Net Income)	4.76x	0.37x	0.68x	0.73x	-0.08x	0.21x	0.54x	0.50x	-0.43x	-0.93x
Interest Paid	0	0	0	0	0	0	435.05K	189K	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-298.81%	-	-923.7%	-172.03%	-	-	-487.23%	-491.92%	-370.02%	-2483.15%
Return on Invested Capital (ROIC)	-409.66%	-	-514.86%	-200.79%	-	-	-	-	-	-
Gross Margin	79.67%	62.85%	70.65%	76.35%	79.75%	76.24%	80.62%	84.32%	87.61%	88.67%
Net Margin	-5.09%	-21.14%	-23.86%	-14.91%	-25.16%	-157.26%	-65.57%	-38.25%	-13.5%	-8.89%
Debt / Equity	0.55x	-	0.27x	0.30x	-	-	0.07x	-	3.40x	-
Interest Coverage	-7.00x	-24.16x	-10.62x	-5.80x	-3.80x	-34.67x	-17.98x	-34.05x	-5.58x	-7.40x
FCF Conversion	4.76x	0.37x	0.68x	0.73x	-0.08x	0.21x	0.54x	0.50x	-0.43x	-0.93x
Revenue Growth	70.67%	329.79%	-3.51%	64.68%	49.79%	199.1%	149.04%	28.16%	28.15%	39.27%

Revenue by Segment

	2019	2020	2021
Work simpli	-	-	445.84K
Work simpli Growth	-	-	-
Product Revenues, Net	9.92M	30.56M	-
Product Revenues, Net Growth	-	208.04%	-
Software Revenues, Net	2.54M	6.73M	-
Software Revenues, Net Growth	-	165.16%	-
Service Revenues, Net	9.94K	5K	-
Service Revenues, Net Growth	-	-49.71%	-

Frequently Asked Questions

Growth & Financials

LifeMD, Inc. (LFMD) reported $252.3M in revenue for fiscal year 2024. This represents a 33825% increase from $0.7M in 2011.

LifeMD, Inc. (LFMD) grew revenue by 39.3% over the past year. This is strong growth.

LifeMD, Inc. (LFMD) reported a net loss of $4.6M for fiscal year 2024.

Dividend & Returns

Yes, LifeMD, Inc. (LFMD) pays a dividend with a yield of 2.00%. This makes it attractive for income-focused investors.

LifeMD, Inc. (LFMD) has a return on equity (ROE) of -2483.1%. Negative ROE indicates the company is unprofitable.

LifeMD, Inc. (LFMD) generated $17.0M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.